Kaigene, Inc. funding

Kaigene, Inc., a biotechnology company based in Rockville, MD (founded 2021), filed a Form D with the SEC on October 14, 2026 and reported $55M raised of a $73.3M offering.

Amount raised$55M

Offering size$73.3M

Filed with the SECOctober 14, 2026

First saleSeptember 30, 2026

IndustryBiotechnology

SecuritiesEquity

LocationRockville, MD

Founded2021

Entity typeCorporation

Investors so far22

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Oct 14

Other health care rounds in Maryland

OS Therapies Inc$7.2M · Oct 23Biotechnology Accufy Diagnostics, Inc.$2M · Oct 28Biotechnology Drizzle Health, LLC$600K · Nov 10Biotechnology BlueHealer Inc.$1 · Nov 4Biotechnology